You have 9 free searches left this month | for more free features.

Condition

Alveolar Soft Part Sarcoma (1)

Cervical Cancer (1)

Endometrial Cancer (1)

Gynecologic Cancer (1)

Leiomyosarcoma (1)

Ovarian Cancer (1)

Sarcoma,Soft Tissue (1)

Soft-Tissue Sarcoma (1)

Synovial Sarcoma (1)

Overall Status

Active, not recruiting (1)

Available (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Advenchen Laboratories, LLC (3)

Collaborator

Intervention

al3818 (3)

al3818 or placebo (1)

dacarbazine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (2)

Expanded Access (1)

al3818

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sarcoma,Soft Tissue, Gynecologic Cancer Trial (AL3818)

Available

Sarcoma,Soft Tissue
Gynecologic Cancer

AL3818

(no location specified)

Nov 22, 2022

Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )

Active, not recruiting

Alveolar Soft Part Sarcoma
+3 more

AL3818
+2 more

Phoenix, Arizona
+22 more

Nov 1, 2022

Endometrial Cancer, Ovarian Cancer, Cervical Cancer Trial in Chicago, Salt Lake City (AL3818)

Terminated

Endometrial Cancer
+2 more

AL3818

Chicago, Illinois
+1 more

Jun 17, 2019